Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Globaldata Plc (DATA.LN)

Globaldata Plc (DATA.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,637,416
  • Shares Outstanding, K 791,178
  • Annual Sales, $ 273,100 K
  • Annual Income, $ 30,800 K
  • 60-Month Beta N/A
  • Price/Sales 6.08
  • Price/Cash Flow 26.70
  • Price/Book 3.63
Trade DATA.LN with:
  • Price/Earnings ttm 50.49
  • Earnings Per Share ttm 0.04
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.05 (2.27%)
  • Most Recent Dividend 0.015 on 09/05/24
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
207.000 +0.43%
on 09/18/24
230.000 -9.62%
on 09/02/24
-13.120 (-5.94%)
since 08/19/24
3-Month
204.000 +1.90%
on 08/06/24
233.000 -10.78%
on 06/24/24
-15.120 (-6.78%)
since 06/19/24
52-Week
132.000 +57.48%
on 10/10/23
244.000 -14.80%
on 05/13/24
+50.380 (+31.99%)
since 09/19/23

Most Recent Stories

More News
Anglo American and ArcelorMittal Among Leading Mining Companies Associated with Hydrogen Theme | GlobalData Plc

The use of hydrogen as a fuel would allow mining companies to further reduce their greenhouse gas emissions...

DATA.LN : 207.060 (+0.03%)
J&J, AbbVie, and Amgen Among Dominant Players in the Plaque Psoriasis Drugs Market | GlobalData Plc

Sales of Remicade, Stelara, and Tremfya cemented J&J as one of the major companies occupying the PsO market...

DATA.LN : 207.060 (+0.03%)
Merck & Co., Roche, and BMS Among Leading Players in the Non-Small Cell Lung Cancer Drugs Market | GlobalData Plc

Merck & Co. currently holds the position as the market leader based on the success of its agent Keytruda in multiple patient populations and across the...

DATA.LN : 207.060 (+0.03%)
Astrazeneca and Novartis Among Major Players in the HER2-Negative Breast Cancer Drugs Market | GlobalData Plc

AstraZeneca expected to further consolidate its position over the forecast period with upcoming therapy launches and label expansions...

DATA.LN : 207.060 (+0.03%)
Microsoft and Google Leading Cybersecurity M&A Activity | GlobalData Plc

Increasing investments by enterprises in cybersecurity owing to employees working remotely during the pandemic sparked an M&A boom in the tech sector...

DATA.LN : 207.060 (+0.03%)
AbbVie/Roche’s Venclexta is Set to Remain the Acute Myeloid Leukemia Drugs Market Leader | GlobalData Plc

Venclexta will continue to grow during the forecast period, securing its market-leading position despite heavy competition...

DATA.LN : 207.060 (+0.03%)
Avastin to Remain Leader in the Colorectal Cancer Drugs Market | GlobalData Plc

Roche’s anti-angiogenesis drug Avastin (bevacizumab) has held a dominant position in the CRC market for many years...

DATA.LN : 207.060 (+0.03%)
Roche, Merck & Co, and Bayer Among Leading Companies in the Glioblastoma Multiforme Market | GlobalData Plc

The US is expected to retain its position as the largest market for glioblastoma multiforme in 2030...

DATA.LN : 207.060 (+0.03%)
Boehringer Ingelheim and F. Hoffman La Roche Among Key Players in the Idiopathic Pulmonary Fibrosis Market | GlobalData Plc

The late-stage pipeline also features several relative newcomers, including Fibrogen, Liminal Biosciences, and PharmAkea...

DATA.LN : 207.060 (+0.03%)
Johnson & Johnson, AbbVie, and Takeda Among Leading Companies in the Ulcerative Colitis Market | GlobalData Plc

Johnson & Johnson continues to be the market leader in the ulcerative colitis market...

DATA.LN : 207.060 (+0.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 212.000
2nd Resistance Point 211.000
1st Resistance Point 209.000
Last Price 207.060
1st Support Level 206.000
2nd Support Level 205.000
3rd Support Level 203.000

See More

52-Week High 244.000
Last Price 207.060
Fibonacci 61.8% 201.216
Fibonacci 50% 188.000
Fibonacci 38.2% 174.784
52-Week Low 132.000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar